Premature death |
|
|
|
Krewski et al (2009) & Bell et al (2004) |
3900 (2400–5400) |
6700 (4100–9200) |
2900 (1700–4100) |
Lepeule et al (2012) & Levy et al (2005) |
11 000 (6000–15 000) |
18 000 (10 000–26 000) |
8500 (5000–12 000) |
Non-Fatal heart attacks |
|
|
|
Peters et al (2001) |
3200 (780–5600) |
5700 (1400–10 000) |
2100 (520–3700) |
Pooled estimate of four studies |
350 (130–930) |
620 (230–1700) |
230 (84–610) |
Cardiovascular hospital admissions |
820 (360–1500) |
1500 (640–2700) |
540 (240–990) |
Respiratory hospital admissions |
2100 ((590)–4500) |
3600 ((1000)–7500) |
2000 ((550)—4400) |
Respiratory emergency Department visits |
7400 ((180)–20 000) |
12 000 ((380)–33 000) |
7200 (130–21 000) |
Acute bronchitis |
4400 ((1000)–9800) |
8000 ((1900)–18 000) |
2900 ((680)—6500) |
Acute respiratory symptoms |
6 400 000 (3 600 000–9 300 000) |
11 000 000 (6 100 000–15 000 000) |
6 100 000 (3 200 000–9 100 000) |
Aggravated asthma |
1 900 000 ((1 500 000)–4 500 000) |
3 000 000 ((2 400 000)–7 200 000) |
2 000 000 ((1 700 000)—4 900 000) |
Upper respiratory symptoms |
80 000 (14 000–140 000) |
140 000 (26 000–260 000) |
53 000 (9500–95 000) |
Lower respiratory symptoms |
56 000 (21 000–91 000) |
100 000 (39 000–160 000) |
37 000 (14 000–60 000) |
Lost work days |
410 000 (340 000–470 000) |
730 000 (620 000–840 000) |
270 000 (230 000–310 000) |
Lost school days |
1 300 000 (460 000–2 900 000) |
2 100 000 (740 000–4 600 000) |
1 400 000 (510 000–3 200 000) |